{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:47:38Z","timestamp":1776386858298,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["No. 2022YFS0630"],"award-info":[{"award-number":["No. 2022YFS0630"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Luzhou Municipal People\u2019s Government","award":["No. 2020-SYF-28"],"award-info":[{"award-number":["No. 2020-SYF-28"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82072780"],"award-info":[{"award-number":["No. 82072780"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04720-y","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:28:34Z","timestamp":1773156514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatial heterogeneity of malignant molecular markers in glioma revealed by stereotactic biopsy"],"prefix":"10.1007","volume":"17","author":[{"given":"Caohang","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaixi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiping","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"10","key":"4720_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/neuonc\/noad100","volume":"25","author":"F Sahm","year":"2023","unstructured":"Sahm F, Brandner S, Bertero L, et al. Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. Neuro Oncol. 2023;25(10):1731\u201349.","journal-title":"Neuro Oncol"},{"issue":"3","key":"4720_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11060-023-04250-5","volume":"162","author":"DE Reuss","year":"2023","unstructured":"Reuss DE. Updates on the WHO diagnosis of IDH-mutant glioma. J Neurooncol. 2023;162(3):461\u20139.","journal-title":"J Neurooncol"},{"issue":"1","key":"4720_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller M, Wen PY, Chang SM, et al. Glioma Nat Rev Dis Primers. 2024;10(1):33.","journal-title":"Glioma Nat Rev Dis Primers"},{"key":"4720_CR4","doi-asserted-by":"publisher","first-page":"717926","DOI":"10.3389\/fonc.2022.717926","volume":"12","author":"Z Yang","year":"2022","unstructured":"Yang Z, Chen Z, Wang Y, et al. A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma. Front Oncol. 2022;12:717926.","journal-title":"Front Oncol"},{"key":"4720_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ctrv.2018.06.016","volume":"69","author":"M Simonelli","year":"2018","unstructured":"Simonelli M, Persico P, Perrino M, et al. Checkpoint inhibitors as treatment for malignant gliomas: A long way to the top. Cancer Treat Rev. 2018;69:121\u201331.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"4720_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0090-3019(02)00751-6","volume":"58","author":"HH Engelhard","year":"2002","unstructured":"Engelhard HH, Stelea A, Cochran EJ. Oligodendroglioma: pathology and molecular biology. Surg Neurol. 2002;58(2):111\u20137.","journal-title":"Surg Neurol"},{"issue":"17","key":"4720_CR7","first-page":"2584","volume":"124","author":"Q Jin","year":"2011","unstructured":"Jin Q, Zhang W, Qiu XG, et al. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma. Chin Med J. 2011;124(17):2584\u20138.","journal-title":"Chin Med J"},{"issue":"4","key":"4720_CR8","first-page":"754","volume":"50","author":"KR Rathi","year":"2007","unstructured":"Rathi KR, Radotra BD, Khosla VK. Proliferative index in astrocytic tumours. Indian J Pathol Microbiol. 2007;50(4):754\u20138.","journal-title":"Indian J Pathol Microbiol"},{"issue":"1","key":"4720_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1440-1789.2007.00844.x","volume":"28","author":"V Zolota","year":"2008","unstructured":"Zolota V, Tsamandas AC, Aroukatos P, et al. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients\u2019 outcome. Neuropathology. 2008;28(1):35\u201342.","journal-title":"Neuropathology"},{"issue":"1","key":"4720_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/0008-5472.CAN-17-2476","volume":"78","author":"J Caramel","year":"2018","unstructured":"Caramel J, Ligier M, Puisieux A. Pleiotropic Roles for ZEB1 in Cancer. Cancer Res. 2018;78(1):30\u20135.","journal-title":"Cancer Res"},{"issue":"34","key":"4720_CR11","doi-asserted-by":"publisher","first-page":"E3562","DOI":"10.1073\/pnas.1403424111","volume":"111","author":"M Rei","year":"2014","unstructured":"Rei M, Gon\u00e7alves-Sousa N, Lan\u00e7a T, et al. Murine CD27(-) V\u03b36(+) \u03b3\u03b4 T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc Natl Acad Sci U S A. 2014;111(34):E3562\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"4720_CR12","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1007\/s00018-012-1122-2","volume":"69","author":"E S\u00e1nchez-Till\u00f3","year":"2012","unstructured":"S\u00e1nchez-Till\u00f3 E, Liu Y, de Barrios O, et al. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci. 2012;69(20):3429\u201356.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"4720_CR13","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/emmm.201302827","volume":"5","author":"FA Siebzehnrubl","year":"2013","unstructured":"Siebzehnrubl FA, Silver DJ, Tugertimur B, et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med. 2013;5(8):1196\u2013212.","journal-title":"EMBO Mol Med"},{"issue":"6","key":"4720_CR14","first-page":"6781","volume":"18","author":"T Zhang","year":"2019","unstructured":"Zhang T, Wang F, Liao Y, et al. LncRNA AWPPH promotes the invasion and migration of glioma cells through the upregulation of HIF1\u03b1. Oncol Lett. 2019;18(6):6781\u20136.","journal-title":"Oncol Lett"},{"issue":"3","key":"4720_CR15","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2353\/ajpath.2010.091021","volume":"177","author":"EE Bar","year":"2010","unstructured":"Bar EE, Lin A, Mahairaki V, et al. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol. 2010;177(3):1491\u2013502.","journal-title":"Am J Pathol"},{"issue":"3","key":"4720_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/cdd.2011.109","volume":"19","author":"JM Heddleston","year":"2012","unstructured":"Heddleston JM, Wu Q, Rivera M, et al. Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential. Cell Death Differ. 2012;19(3):428\u201339.","journal-title":"Cell Death Differ"},{"issue":"7","key":"4720_CR17","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/cdd.2014.31","volume":"21","author":"B Auffinger","year":"2014","unstructured":"Auffinger B, Tobias AL, Han Y, et al. Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy. Cell Death Differ. 2014;21(7):1119\u201331.","journal-title":"Cell Death Differ"},{"issue":"6","key":"4720_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tcb.2006.04.003","volume":"16","author":"AO Rehman","year":"2006","unstructured":"Rehman AO, Wang CY. Notch signaling in the regulation of tumor angiogenesis. Trends Cell Biol. 2006;16(6):293\u2013300.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"4720_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","volume":"137","author":"R Kopan","year":"2009","unstructured":"Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216\u201333.","journal-title":"Cell"},{"issue":"2","key":"4720_CR20","doi-asserted-by":"publisher","first-page":"e9258","DOI":"10.1371\/journal.pone.0009258","volume":"5","author":"A Dumortier","year":"2010","unstructured":"Dumortier A, Durham AD, Di Piazza M, et al. Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLoS ONE. 2010;5(2):e9258.","journal-title":"PLoS ONE"},{"issue":"1","key":"4720_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13046-019-1319-4","volume":"38","author":"L Yi","year":"2019","unstructured":"Yi L, Zhou X, Li T, et al. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12\/CXCR4. J Exp Clin Cancer Res. 2019;38(1):339.","journal-title":"J Exp Clin Cancer Res"},{"issue":"20","key":"4720_CR22","doi-asserted-by":"publisher","first-page":"33353","DOI":"10.18632\/oncotarget.16495","volume":"8","author":"C Zhang","year":"2017","unstructured":"Zhang C, Hai L, Zhu M, et al. Actin cytoskeleton regulator Arp2\/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells. Oncotarget. 2017;8(20):33353\u201364.","journal-title":"Oncotarget"},{"issue":"10","key":"4720_CR23","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/neuonc\/noaa064","volume":"22","author":"EJ Lim","year":"2020","unstructured":"Lim EJ, Kim S, Oh Y, et al. Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a\/p38\/ZEB1 axis. Neuro Oncol. 2020;22(10):1452\u201362.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4720_CR24","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1038\/s41598-017-06086-2","volume":"7","author":"P Wang","year":"2017","unstructured":"Wang P, Wan W, Xiong S, et al. HIF1\u03b1 regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels. Sci Rep. 2017;7(1):7965.","journal-title":"Sci Rep"},{"issue":"1","key":"4720_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/jca.54402","volume":"13","author":"P Wang","year":"2022","unstructured":"Wang P, Gong S, Liao B, et al. HIF1\u03b1\/HIF2\u03b1 induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions. J Cancer. 2022;13(1):1\u201314.","journal-title":"J Cancer"},{"issue":"6","key":"4720_CR26","doi-asserted-by":"publisher","first-page":"e0129603","DOI":"10.1371\/journal.pone.0129603","volume":"10","author":"W Zhang","year":"2015","unstructured":"Zhang W, Shi X, Peng Y, et al. HIF-1\u03b1 Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer. PLoS ONE. 2015;10(6):e0129603.","journal-title":"PLoS ONE"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04720-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:54:28Z","timestamp":1776383668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04720-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4720"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04720-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants consented to the publication of anonymized data and findings derived from their samples and clinical information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"584"}}